Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 228-567-1 | CAS number: 6297-03-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- June 20 - Sp 18, 2008 (main study) or Oct 30, 2008 (recovery animals)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: according to OECD guideline 408 under GLP conditions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- Guideline:
- EU Method B.26 (Sub-Chronic Oral Toxicity Test: Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Dioctylether
- IUPAC Name:
- Dioctylether
- Reference substance name:
- Dioctyl ether
- EC Number:
- 211-112-6
- EC Name:
- Dioctyl ether
- Cas Number:
- 629-82-3
- IUPAC Name:
- 1,1'-oxydioctane
- Details on test material:
- - Name of test material (as cited in study report): C-SAT 080029
- Physical state: colourless liquid
- Analytical purity: 99.1%
- Composition of test material, percentage of components: dioctylether: 99.1%
- Purity test date: February 27, 2008
- Lot/batch No.: CE72530027
- Expiration date of the lot/batch: September 09, 2009
- Stability under test conditions: September 09, 2009
- Storage condition of test material: at room temperature
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Germany GmbH, 97633 Sulzfeld, Germany
- Age at study initiation: at start of adaptation: males: 26 days, females: 27 days
- Weight at study initiation: at start of adaptation: males: 72.9-84.0 g; females: 70.9-82.9 g
- Fasting period before study: no
- Housing: singly
- Diet (e.g. ad libitum): conventional laboratory diet ad libitum
- Water (e.g. ad libitum): drinking water ad libitum
- Acclimation period: 9 adaptation days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C +/- 3°C (maximum range)
- Humidity (%): 55% +/- 15% (maximum range)
- Air changes (per hr): 12 - 18 times
- Photoperiod (hrs dark / hrs light): 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: June 20, 2008 To: September 18, 2008 (main study animals) or October 30, 2008 (recovery animals)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: sunflower oil
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test item-vehicle mixtures were freshly prepared every day. The test item was suspended in the vehicle (sunflower oil) to the appropriate
concentrations and was administered orally by gavage at a constant volume of 5 mL/kg b.w. daily for 90 days.
DIET PREPARATION
- Rate of preparation of diet (frequency):
- Mixing appropriate amounts with (Type of food):
- Storage temperature of food:
VEHICLE
- Justification for use and choice of vehicle (if other than water): most suitable vehicle
- Concentration in vehicle: 0.02, 0.06, 0.2 mg/mL
- Amount of vehicle (if gavage): 5 mL/kg b.w.day
- Lot/batch no. (if required): product no. 88921, LOT: 1379622
- Purity: 100% - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The determination of the concentration of C-SAT 080029 in the vehicle sunflower oil was performed using a gas chromatography (GC) method with FID detection.
The concentration of C-SAT 080029 in the mixture was quantified using a calibration curve calculated from defined peak areas of the test item. The
analytical method used was developed and validated by LPT for linearity of the calibration curve, accuracy, precision, stability, specificity and
sensitivity.
The measured concentrations ranged from 100.43% to 109.72% of the theoretical value and were well within the admissible limits. - Duration of treatment / exposure:
- 90 days
- Frequency of treatment:
- once daily, 7 days each week for 90 days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100, 300, 1000 mg/kg b.w./day
Basis:
actual ingested
- No. of animals per sex per dose:
- main study: 10 animals / sex / group in groups 1 to 4; recovery period: 5 animals / sex / group in groups 1 and 4
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: based on the results of a 7-day dose-range-finding study (LPT Study No. 22830)
- Rationale for animal assignment (if not random): rats were selected because of their proven suitability in toxicology studies and to comply with
regulatory requirements for testing in a rodent animal species
- Rationale for selecting satellite groups:
- Post-exposure recovery period in satellite groups: 6-week recovery period
- Section schedule rationale (if not random):
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes / No / No data
- Time schedule: regularly throughout the working day from 7:30 a.m. to 4:30 p.m., on Saturdays and Sundays from 8:00 a.m. to 12:00 p.m. with a
final check at approx. 4:00 p.m.
- Cage side observations checked: skin/fur, eyes, mucous membranes, respiratory and circulatory systems, somatomotor activity and behaviour
patterns
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: at least once daily
BODY WEIGHT: Yes
- Time schedule for examinations: at the time of allocation of animals to groups, on the day of commencement of treatment and weekly thereafter
always on the same day of the week throughout the experimental period
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data:
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study):
- Time schedule for examinations:
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: prior to start of administration and at study termination (main study and recovery period)
- Dose groups that were examined: all dose groups
HAEMATOLOGY: Yes
- Time schedule for collection of blood: at main study termination (on the first day of dissection); at the end of the recovery period
- Anaesthetic used for blood collection: Yes (ether)
- Animals fasted: Yes (overnight)
- How many animals: 10 / sex / group
- Parameters examined: haemoglobin content (HGB), erythrocytes (RBC), leucocytes (WBC), reticulocytes (reti), platelets (PCT), differential blood
count (relative and absolute), haematocrit value (HCT), thromboplastin time (TPT), activated partial thromboplastin time (aPTT), mean corpuscular
volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin (MCHC)
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: at main study termination (on the first day of dissection); at the end of the recovery period
- Animals fasted: Yes (overnight)
- How many animals: 10 / sex / group
- Parameters examined: albumin, globulin, albumin/globulin ratio, bilirubin (total), cholesterol (total), creatinine, glucose, protein (total), triglycerides, urea (blood urea nitrogen), calcium, chloride, potassium, sodium, alanine aminotransferase (ALAT), alkaline phosphatase (aP), aspartate aminotransferase (ASAT), lactate dehydrogenase (LDH)
URINALYSIS: Yes
- Time schedule for collection of urine: at main study termination (on the first day of dissection); at the end of the recovery period
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Yes (overnight)
- Parameters examined: volume, pH, specific gravity, protein, glucose, bilirubin, urobilinogen, ketones, haemoglobin, nitrite
microscopic examination of deposits (epithelial cells, leucocytes, erythrocytes, organisms, further constituents (i.e. sperm, casts), crystalluria)
NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: in test week 13 approx. 1 - 2 hours after dosing and before any blood sampling
- Dose groups that were examined: all dose groups
- Battery of functions tested: sensory activity / grip strength / motor activity
OTHER: Observational screening (righting reflex, body temperature, salivation, startle response, respiration, mouth breathing, urination, convulsions, pilo-erection, diarrhoea, pupil size, pupil response, lacrimation, impaired gait, stereotypy, toe pinch, tail pinch, wire manoeuvre, hind leg splay, positional passivity, tremors, positive geotropism, lim rotation and auditory function) - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, in all animals of all groups
HISTOPATHOLOGY: Yes, restricted to gropus 1 (vehicle control) and group 4 (high dose) - Statistics:
- Students; t-test: all numerical function tests / urinalysis
Multiple t-test based on Dunnett, C.W.: body weight, food consumption, haematology, clinical biochemistry, organ weights (absolute and relative)
Exact test of R.A. Fisher: histopathology
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- CLINICAL SIGNS AND MORTALITY
No test item-related mortality occurred. No test item-related clinical signs of systemic toxicity were noted in the animals treated with
100, 300 or 1000 mg C-SAT 080029/kg b.w./day. The faeces of all the control and test itemtreated animals showed a normal consistency
during the entire treatment period.
BODY WEIGHT AND WEIGHT GAIN
Body weight and body weight gain were not influenced in male and female rats treated with 100, 300 or 1000 mg C-SAT 080029/kg b.w./day.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)
No feeding study
FOOD EFFICIENCY
No test item-related influence was noted on the food consumption for the male and female rats of all groups treated with the test item.
The visual appraisal of the drinking water consumption revealed no differences between the control and the test item-treated animals.
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study)
No drinking water study.
OPHTHALMOSCOPIC EXAMINATION
Ophthalmological examinations of the ocular structures revealed no lesions of the eyes or the optic region.
HAEMATOLOGY
No test item related influence was noted.
CLINICAL CHEMISTRY
No test item related influence was noted.
URINALYSIS
No test item related influence was noted.
NEUROBEHAVIOUR
The observational and functional screening in test week 13 approximately 1 to 2 hours after application did not reveal any test item-related
changes at any dose level. No influence was noted on fore- and hindlimb grip strength or spontaneous motility.
ORGAN WEIGHTS
The increased liver weights (relative and sbsolute) and kidney weights (absolute) noted in the high dosed male and female rats are considered to be a non-specific change to the high work load of the liver and kidney caused by the high dose level of 1000 mg/kg b.w./day.
GROSS PATHOLOGY
Macroscopic inspection at necropsy did not reveal any changes in the organs and tissues of the rats treated with 100, 300 or 1000 mg CSAT
080029/kg b.w./day.
HISTOPATHOLOGY: NON-NEOPLASTIC
The histopathological examination of the animals treated with 1000 mg C-SAT 080029/kg b.w./day for 90 days did not reveal any morphological
lesions which are considered to be test item-related.
HISTOPATHOLOGY: NEOPLASTIC (if applicable)
HISTORICAL CONTROL DATA (if applicable)
OTHER FINDINGS
ORGAN WEIGHTS: The increased liver weights (relative and absolute) and kidney weights (absolute) noted in the high dosed male and female rats are considered to be a non-specific adaptive change to the high work load of the liver and kidney caused by the high dose level of 1000 mg/kg b.w./day.
Effect levels
- Dose descriptor:
- NOEL
- Effect level:
- > 1 000 mg/kg bw/day (actual dose received)
- Sex:
- male/female
- Basis for effect level:
- other: overall effects clinical signs; mortality; body weight; food consumption; food efficiency; water consumption and compound intake; ophthalmoscopic examination; haematology; clinical chemistry; urinalysis; gross pathology; organ weights; histopathology
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.